CAS 113662-54-7|Neuropeptide Y (13-36) (porcine) trifluoroacetate salt
| Common Name | Neuropeptide Y (13-36) (porcine) trifluoroacetate salt | ||
|---|---|---|---|
| CAS Number | 113662-54-7 | Molecular Weight | 2982.36000 |
| Density | / | Boiling Point | / |
| Molecular Formula | C135H209N41O36 | Melting Point | / |
| MSDS | USA | Flash Point | / |
Names
| Name | Neuropeptide Y Fragment 13-36 porcine |
|---|---|
| Synonym | More Synonyms |
BiologicalActivity
| Description | Neuropeptide Y (13-36), porcine is a selective neuropeptide Y2 receptor agonist[1]. |
|---|---|
| Related Catalog | Research Areas >>Neurological DiseaseSignaling Pathways >>GPCR/G Protein >>Neuropeptide Y Receptor |
| References | [1]. Aguirre JA, et al. Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat. Neurosci Lett. 1990 Oct 2;118(1):5-8. |
Chemical & Physical Properties
| Molecular Formula | C135H209N41O36 |
|---|---|
| Molecular Weight | 2982.36000 |
| Exact Mass | 2980.58000 |
| PSA | 1282.86000 |
| LogP | 5.51400 |
| InChIKey | HEALDAASUSTTPJ-QGTLAHJGSA-N |
| SMILES | CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1cnc[nH]1)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C1CCCN1)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(N)=O)C(C)O)C(C)CC |
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
Articles3
More Articles| Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices. J. Neurochem. 73 , 641-646, (1999) Neuropeptide Y (NPY) is an important regulator of energy balance in mammals through its orexigenic, antithermogenic, and insulin secretagogue actions. We investigated the regulation of endogenous NPY ... | |
| Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 19 , 359-363, (1998) In the present study, the effects of intracerebroventricular (ICV) NPY, [Leu31, Pro34]NPY and NPY13-36 have been evaluated with respect to anxiety in mice in the elevated plus maze. NPY had opposing e... | |
| Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes. Eur. J. Pharmacol. 336 , 257, (1997) The aim of this study was to confirm the existence of and identify the receptor subtypes for neuropeptide Y that are present post-junctionally in myocardium. The effects of the selective agonists, [Le... |
Synonyms
| npy 13-36 |
| PAEDLARYYSALRHYINLITRQRY-NH2 |
